Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults
- PMID: 27567324
- PMCID: PMC5175477
- DOI: 10.1016/j.pscychresns.2016.08.002
Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults
Abstract
The serotonin neurotransmitter system is modulated in part by the uptake of synaptically released serotonin (5-HT) by the serotonin transporter (5-HTT), and by specific serotonin autoreceptors such as the somatodendritic 5-HT1A receptor, which can limit serotonin neuron depolarization. However, little is known about how 5-HTT and 5-HT1A are related in vivo. To study this question, we reanalyzed positron emission tomography (PET) data obtained earlier in 40 healthy participants (21 females) using [(11)C]WAY-100635 for quantification of 5-HT1A binding and [(11)C](+)-McN-5652 for quantification of 5-HTT binding. We hypothesized negative correlations between 5-HT1A binding in the raphe nuclei (RN) and 5-HTT binding in RN terminal field regions. Controlling for sex, no significant correlations were found (all p>0.05). Similarly, an exploratory analysis correlating whole-brain voxel-wise 5-HTT binding with 5-HT1A binding in RN identified no significant clusters meeting our a priori statistical threshold. The lack of correlation between 5-HT1A and 5-HTT binding observed in the current study may be due to the different temporal responsiveness of regulatory processes controlling the somatodendritic 5-HT1A receptor and 5-HTT in response to changing availability of intrasynaptic serotonin.
Keywords: PET; Serotonin; Serotonin 1A receptor; Serotonin transporter.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Figures
Similar articles
-
5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.Eur Neuropsychopharmacol. 2013 Oct;23(10):1190-8. doi: 10.1016/j.euroneuro.2013.01.002. Epub 2013 Feb 18. Eur Neuropsychopharmacol. 2013. PMID: 23428337 Clinical Trial.
-
Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.PLoS One. 2014 Sep 4;9(9):e106810. doi: 10.1371/journal.pone.0106810. eCollection 2014. PLoS One. 2014. PMID: 25188405 Free PMC article.
-
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.Neuroimage. 2008 Feb 1;39(3):1408-19. doi: 10.1016/j.neuroimage.2007.10.016. Epub 2007 Oct 25. Neuroimage. 2008. PMID: 18036835
-
Serotonin-1A receptor imaging in recurrent depression: replication and literature review.Nucl Med Biol. 2007 Oct;34(7):865-77. doi: 10.1016/j.nucmedbio.2007.06.008. Nucl Med Biol. 2007. PMID: 17921037 Free PMC article. Review.
-
PET tracers for 5-HT(1A) receptors and uses thereof.Drug Discov Today. 2007 Sep;12(17-18):748-56. doi: 10.1016/j.drudis.2007.07.008. Epub 2007 Aug 27. Drug Discov Today. 2007. PMID: 17826688 Review.
Cited by
-
In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study.Neuropsychopharmacology. 2022 Sep;47(10):1863-1868. doi: 10.1038/s41386-022-01369-3. Epub 2022 Jul 11. Neuropsychopharmacology. 2022. PMID: 35821068 Free PMC article.
-
Molecular connectivity disruptions in males with major depressive disorder.J Cereb Blood Flow Metab. 2019 Aug;39(8):1623-1634. doi: 10.1177/0271678X18764053. Epub 2018 Mar 9. J Cereb Blood Flow Metab. 2019. PMID: 29519187 Free PMC article.
-
Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.J Nucl Med. 2018 Apr;59(4):665-670. doi: 10.2967/jnumed.117.189654. Epub 2017 Sep 21. J Nucl Med. 2018. PMID: 28935838 Free PMC article. Clinical Trial.
-
In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry.Front Neurosci. 2019 Apr 23;13:362. doi: 10.3389/fnins.2019.00362. eCollection 2019. Front Neurosci. 2019. PMID: 31110471 Free PMC article.
-
A positron emission tomography study of the serotonergic system in relation to anxiety in depression.Eur Neuropsychopharmacol. 2017 Oct;27(10):1011-1021. doi: 10.1016/j.euroneuro.2017.07.009. Epub 2017 Aug 12. Eur Neuropsychopharmacol. 2017. PMID: 28811068 Free PMC article.
References
-
- Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995;688:121–133. - PubMed
-
- Baldinger P, Kraus C, Rami-Mark C, Gryglewski G, Kranz GS, Haeusler D, Hahn A, Spies M, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R. Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding. NeuroImage. 2015;111:505–512. - PubMed
-
- Blier P, de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology. 1999;21:91S–98S. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources